JP2003528577A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003528577A5 JP2003528577A5 JP2001513421A JP2001513421A JP2003528577A5 JP 2003528577 A5 JP2003528577 A5 JP 2003528577A5 JP 2001513421 A JP2001513421 A JP 2001513421A JP 2001513421 A JP2001513421 A JP 2001513421A JP 2003528577 A5 JP2003528577 A5 JP 2003528577A5
- Authority
- JP
- Japan
- Prior art keywords
- thymidine
- uridine
- monophosphate
- triphosphate
- adenosine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 2
- 210000001865 kupffer cell Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- XKMLYUALXHKNFT-UUOKFMHZSA-N Guanosine-5'-triphosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XKMLYUALXHKNFT-UUOKFMHZSA-N 0.000 description 1
- FULZLIGZKMKICU-UHFFFAOYSA-N N-phenylthiourea Chemical compound NC(=S)NC1=CC=CC=C1 FULZLIGZKMKICU-UHFFFAOYSA-N 0.000 description 1
- RZCIEJXAILMSQK-JXOAFFINSA-N TTP Chemical compound O=C1NC(=O)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 RZCIEJXAILMSQK-JXOAFFINSA-N 0.000 description 1
- PGAVKCOVUIYSFO-XVFCMESISA-N UTP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 PGAVKCOVUIYSFO-XVFCMESISA-N 0.000 description 1
- XCCTYIAWTASOJW-XVFCMESISA-N Uridine-5'-Diphosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 XCCTYIAWTASOJW-XVFCMESISA-N 0.000 description 1
- DJJCXFVJDGTHFX-UHFFFAOYSA-N Uridinemonophosphate Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-UHFFFAOYSA-N 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
- LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 description 1
- 229960003190 adenosine monophosphate Drugs 0.000 description 1
- 229960001456 adenosine triphosphate Drugs 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- UJLXYODCHAELLY-XLPZGREQSA-N dTDP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 UJLXYODCHAELLY-XLPZGREQSA-N 0.000 description 1
- GYOZYWVXFNDGLU-XLPZGREQSA-N dTMP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)C1 GYOZYWVXFNDGLU-XLPZGREQSA-N 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 229940029575 guanosine Drugs 0.000 description 1
- 235000013928 guanylic acid Nutrition 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- DJJCXFVJDGTHFX-XVFCMESISA-N uridine 5'-monophosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-XVFCMESISA-N 0.000 description 1
- 229950010342 uridine triphosphate Drugs 0.000 description 1
- PGAVKCOVUIYSFO-UHFFFAOYSA-N uridine-triphosphate Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 PGAVKCOVUIYSFO-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14627299P | 1999-07-29 | 1999-07-29 | |
| US60/146,272 | 1999-07-29 | ||
| US16855599P | 1999-12-02 | 1999-12-02 | |
| US60/168,555 | 1999-12-02 | ||
| PCT/US2000/021015 WO2001008691A1 (en) | 1999-07-29 | 2000-07-31 | Methods for transdifferentiation of body tissues |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011021729A Division JP2011139705A (ja) | 1999-07-29 | 2011-02-03 | 身体組織の分化転換方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003528577A JP2003528577A (ja) | 2003-09-30 |
| JP2003528577A5 true JP2003528577A5 (https=) | 2007-10-04 |
Family
ID=26843741
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001513421A Pending JP2003528577A (ja) | 1999-07-29 | 2000-07-31 | 身体組織の分化転換方法 |
| JP2011021729A Withdrawn JP2011139705A (ja) | 1999-07-29 | 2011-02-03 | 身体組織の分化転換方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011021729A Withdrawn JP2011139705A (ja) | 1999-07-29 | 2011-02-03 | 身体組織の分化転換方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US6670397B1 (https=) |
| EP (1) | EP1200101A4 (https=) |
| JP (2) | JP2003528577A (https=) |
| AU (1) | AU782396B2 (https=) |
| CA (1) | CA2378140A1 (https=) |
| IL (2) | IL147669A0 (https=) |
| WO (1) | WO2001008691A1 (https=) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1200101A4 (en) * | 1999-07-29 | 2003-02-05 | Steven Baranowitz | METHODS FOR TRANSDIFFERENTIATING BODY TISSUES |
| US20070087993A1 (en) * | 1999-07-29 | 2007-04-19 | Steven Baranowitz | Method for transdifferentiation of body tissues |
| US8609412B2 (en) | 1999-08-05 | 2013-12-17 | Regents Of The University Of Minnesota | Mapc generation of lung tissue |
| US8252280B1 (en) | 1999-08-05 | 2012-08-28 | Regents Of The University Of Minnesota | MAPC generation of muscle |
| US7015037B1 (en) | 1999-08-05 | 2006-03-21 | Regents Of The University Of Minnesota | Multiponent adult stem cells and methods for isolation |
| US10638734B2 (en) | 2004-01-05 | 2020-05-05 | Abt Holding Company | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| WO2002064748A2 (en) | 2001-02-14 | 2002-08-22 | Furcht Leo T | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| WO2001011011A2 (en) | 1999-08-05 | 2001-02-15 | Mcl Llc | Multipotent adult stem cells and methods for isolation |
| NL1017973C2 (nl) * | 2000-05-10 | 2002-11-08 | Tristem Trading Cyprus Ltd | Inrichting. |
| US6864243B1 (en) | 2000-05-12 | 2005-03-08 | Inspire Pharmaceuticals, Inc. | Method for treating retinal degeneration with purinergic receptor agonists |
| AU2003202988A1 (en) * | 2002-01-14 | 2003-07-30 | The Board Of Trustees Of The University Of Illinois | Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| US20060228798A1 (en) | 2002-11-27 | 2006-10-12 | Catherine Verfaillie | Homologous recombination in multipotent adult progenitor cells |
| AU2003300012A1 (en) * | 2002-12-30 | 2004-07-29 | Indiana University Research & Technology Corporation | Method of treatment for central nervous system injury |
| JP2007508816A (ja) * | 2003-10-10 | 2007-04-12 | ゲ・ミン・ルイ | 細胞培養および組織培養プラットフォームのための組成物および方法 |
| RU2319132C2 (ru) * | 2005-08-24 | 2008-03-10 | Надежда Витальевна Корсакова | Усовершенствованный способ выявления клеточных структур в хрусталике глаза экспериментальных животных |
| CN101310012B (zh) | 2005-10-14 | 2012-05-09 | 明尼苏达大学董事会 | 非胚胎干细胞分化成具有胰腺表型的细胞 |
| WO2008063675A2 (en) | 2006-11-24 | 2008-05-29 | Regents Of The University Of Minnesota | Endodermal progenitor cells |
| US7897363B2 (en) * | 2007-06-12 | 2011-03-01 | Phylonix Pharmaceuticals, Inc. | Methods of screening an agent for an activity in an isolated eye of a teleost |
| AU2009205886B2 (en) | 2008-01-18 | 2015-08-27 | Katholieke Universiteit Leuven | Stem cell aggregates and methods for making and using |
| WO2010049752A1 (en) | 2008-10-31 | 2010-05-06 | Katholieke Universiteit Leuven | Optimized methods for differentiation of cells into cells with hepatocyte and hepatocyte progenitor phenotypes, cells produced by the methods, and methods for using the cells |
| TWI450228B (zh) * | 2010-01-15 | 2014-08-21 | 私立中原大學 | A method of simulating spinal surgery on a computer system |
| SG185526A1 (en) | 2010-05-12 | 2012-12-28 | Abt Holding Co | Modulation of splenocytes in cell therapy |
| WO2011158125A2 (en) | 2010-06-17 | 2011-12-22 | Katholieke Universiteit Leuven | Methods for differentiating cells into hepatic stellate cells and hepatic sinusoidal endothelial cells, cells produced by the methods, and methods for using the cells |
| EP2609191B1 (en) | 2010-08-24 | 2017-11-22 | Regents Of The University Of Minnesota | Non-static suspension culture of cell aggregates |
| IL289870B2 (en) | 2013-04-12 | 2023-03-01 | Lafrancesca Saverio | Improving organs for transplantation |
| CA2978109A1 (en) | 2015-03-31 | 2016-10-06 | The University Of North Carolina At Chapel Hill | Delivery vehicles for stem cells and uses thereof |
| NL2019618B1 (en) | 2017-09-22 | 2019-03-28 | Ncardia B V | In vitro method for providing stem cell derived cardiomyocytes |
| JP2020537522A (ja) | 2017-10-13 | 2020-12-24 | イーエムベーアー−インスティテュート フュール モレクラレ バイオテクノロジー ゲゼルシャフト ミット ベシュレンクテル ハフツング | 体細胞の増強された再プログラミング |
| US20230134859A1 (en) * | 2020-03-31 | 2023-05-04 | Sky Pharma Co., Ltd. | Method for screening for, method for producing, and method for designing drug active ingredients |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7319994A (en) * | 1993-06-30 | 1995-01-24 | Board Of Regents, The University Of Texas System | Nucleotide preparation and uses thereof in wound healing |
| US6087168A (en) * | 1999-01-20 | 2000-07-11 | Cedars Sinai Medical Center | Conversion of non-neuronal cells into neurons: transdifferentiation of epidermal cells |
| EP1200101A4 (en) * | 1999-07-29 | 2003-02-05 | Steven Baranowitz | METHODS FOR TRANSDIFFERENTIATING BODY TISSUES |
-
2000
- 2000-07-31 EP EP00955323A patent/EP1200101A4/en not_active Ceased
- 2000-07-31 AU AU67545/00A patent/AU782396B2/en not_active Ceased
- 2000-07-31 US US09/856,881 patent/US6670397B1/en not_active Expired - Lifetime
- 2000-07-31 IL IL14766900A patent/IL147669A0/xx unknown
- 2000-07-31 CA CA002378140A patent/CA2378140A1/en not_active Abandoned
- 2000-07-31 WO PCT/US2000/021015 patent/WO2001008691A1/en not_active Ceased
- 2000-07-31 JP JP2001513421A patent/JP2003528577A/ja active Pending
-
2002
- 2002-01-16 IL IL147669A patent/IL147669A/en not_active IP Right Cessation
-
2003
- 2003-06-19 US US10/600,745 patent/US7176189B2/en not_active Expired - Fee Related
-
2011
- 2011-02-03 JP JP2011021729A patent/JP2011139705A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003528577A5 (https=) | ||
| WO2004055167A3 (en) | Alphavirus particles and methods for preparation | |
| JP2004534769A5 (https=) | ||
| CA107089S (en) | Computer monitor | |
| JP2003192699A5 (https=) | ||
| JP2004161535A5 (https=) | ||
| JP2022514684A5 (https=) | ||
| WO2006003156A8 (en) | Sodium percarbonate particles, process for their production, their use and detergent compositions containing them | |
| WO2004002398A3 (en) | Spherical pellet containing a water-soluble active ingredient | |
| FR2848430B1 (fr) | Composition capillaire comprenant un copolymere filmogene a gradient, composition aerosol la comprenant et procedes de traitement | |
| JP2006521133A5 (https=) | ||
| USD500795S1 (en) | Writing end of an electronic pen | |
| WO2004026261A3 (en) | Composition containing ribavirin and use thereof | |
| Annadurai | Box-Behnken Studies on Dye Removal form Water Using Chitosan and Activated Carbon Adsorbents | |
| JP2003206224A5 (https=) | ||
| JP2001299381A5 (https=) | ||
| Denissen | ENERGY EFFICIENT DRYING. PT. 1. ENERGY EFFICIENCY OF VARIOUS TECHNIQUES IN CONVECTIVE DRYING | |
| JPS5799199A (en) | Preparation of 8-adenosyl-l-methionine | |
| Ji et al. | A model equation for simulating flow-field in multirow axial turbomachines | |
| Panov | Helical rolling of solid billet: radial stresses. | |
| RU2004127273A (ru) | Способ получения биологически активного вещества | |
| Garnerin | Role of mating and weaning of young foxes in the winter incidence of vulpine rabies: A biomathematical approach.). | |
| Židovec Lepej et al. | Immunologic reconstruction during 1 year of HAART in patients treated in Zagreb, Croatia | |
| RU97115025A (ru) | Способ диагностики активного туберкулеза женских половых органов | |
| 谷湘潜 et al. | A new method to improve the precision of time difference |